These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26739543)

  • 1. Enoxaparin Treatment Followed by Rivaroxaban for the Treatment of Acute Lower Limb Venous Thromboembolism: Initial Experience in a Single Center.
    Wolosker N; Varella AY; Fukuda JM; Teivelis M; Kuzniec S; Krutman M; Guerra JC; Ramacciotti E
    Clin Appl Thromb Hemost; 2016 May; 22(4):377-80. PubMed ID: 26739543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Rivaroxaban in Children with Congenital Heart Disease: A Single-Center Case Series.
    Duran S; Gerber C; Bilsky S; Plummer S; Bocks M
    Pediatr Cardiol; 2024 Aug; 45(6):1295-1300. PubMed ID: 36681724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network.
    Hartmann S; Biliouris K; Lesko LJ; Nowak-Göttl U; Trame MN
    CPT Pharmacometrics Syst Pharmacol; 2016 Oct; 5(10):554-564. PubMed ID: 27647667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban versus enoxaparin plus clopidogrel therapy for hypertrophic cardiomyopathy-associated thromboembolism in cats.
    Jaturanratsamee K; Jiwaganont P; Panprom C; Petchdee S
    Vet World; 2024 Apr; 17(4):796-803. PubMed ID: 38798301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conception of a Personalized Medication Adherence Discharge Kit for Rivaroxaban.
    Stern GM; Pitlick JM; Stacy ZA; Crannage AJ
    Hosp Pharm; 2016 Jan; 51(1):60-67. PubMed ID: 38745710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enoxaparin is safe for the treatment of venous thromboembolisms in patients with renal dysfunction: A retrospective cohort study.
    Flynn C; Baldassarra J; Hamidi A
    Thromb Res; 2024 Apr; 236():127-129. PubMed ID: 38430903
    [No Abstract]   [Full Text] [Related]  

  • 7. Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric Population.
    von Vajna E; Alam R; So TY
    Cardiol Ther; 2016 Jun; 5(1):19-41. PubMed ID: 26739579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin.
    Ricket AL; Stewart DW; Wood RC; Cornett L; Odle B; Cluck D; Freshour J; El-Bazouni H
    Ann Pharmacother; 2016 Apr; 50(4):270-5. PubMed ID: 26783354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment.
    Burnett AE; Mahan CE; Vazquez SR; Oertel LB; Garcia DA; Ansell J
    J Thromb Thrombolysis; 2016 Jan; 41(1):206-32. PubMed ID: 26780747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban-treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding.
    Kline JA; Jimenez D; Courtney DM; Ianus J; Cao L; Lensing AW; Prins MH; Wells PS
    Acad Emerg Med; 2016 Feb; 23(2):144-50. PubMed ID: 26765080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and persistence of non-vitamin-K-antagonist oral anticoagulants in atrial fibrillation patients treated in a well structured atrial fibrillation clinic.
    Al-Khalili F; Lindström C; Benson L
    Curr Med Res Opin; 2016; 32(4):779-85. PubMed ID: 26765366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions.
    Monaco L; Biagi C; Conti V; Melis M; Donati M; Venegoni M; Vaccheri A; Motola D
    Br J Clin Pharmacol; 2017 Jul; 83(7):1532-1543. PubMed ID: 28071818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study.
    Abraham NS; Noseworthy PA; Yao X; Sangaralingham LR; Shah ND
    Gastroenterology; 2017 Apr; 152(5):1014-1022.e1. PubMed ID: 28043907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Features of application of Factor Xa inhibitor at patients with damages of large segments of the lower extremities].
    Fayzullin AA; Minasov TB; Usatova OS; Mukhamedyanova LI; Gafarov IR
    Khirurgiia (Mosk); 2015; (9):74-78. PubMed ID: 26762082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Periprocedural and Early Pericardial Effusions With Tamponade Following Ablation of Atrial Fibrillation With Uninterrupted Factor Xa Inhibitors: A Case Series.
    Gianni C; DI Biase L; Mohanty S; Trivedi C; Bai R; Al-Ahmad A; Burkhardt JD; Gallinghouse GJ; Horton RP; Sanchez JE; Hranitzky PM; Lakkireddy D; Mansour MC; Santangeli P; Zado ES; Marchlinski FE; Beheiry S; Hao SC; Couts L; Gibson D; Natale A
    J Cardiovasc Electrophysiol; 2016 Apr; 27(4):399-403. PubMed ID: 26756289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis.
    Riva N; Dentali F; Permunian ET; Ageno W
    Semin Thromb Hemost; 2016 Feb; 42(1):42-54. PubMed ID: 26751034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants.
    Morais J; De Caterina R
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):201-14. PubMed ID: 26780749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct new oral anticoagulants in the emergency department: Experience in everyday clinical practice at a Swiss university hospital.
    Sauter TC; Amylidi AL; Ricklin ME; Lehmann B; Exadaktylos AK
    Eur J Intern Med; 2016 Apr; 29():e13-5. PubMed ID: 26777104
    [No Abstract]   [Full Text] [Related]  

  • 20. Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention.
    Andrade JG; Krahn AD; Skanes AC; Purdham D; Ciaccia A; Connors S
    Can J Cardiol; 2016 Jun; 32(6):747-53. PubMed ID: 26774235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.